AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹245 Cr | ₹359 Cr | ₹133 Cr | ₹70 Cr | ₹155 Cr |
What is the latest Cash Flow from Operating Activities ratio of AARTI DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹359 Cr |
| Mar2023 | ₹133 Cr |
| Mar2022 | ₹70 Cr |
| Mar2021 | ₹155 Cr |
How is Cash Flow from Operating Activities of AARTI DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹245 Cr | -31.86 | |
| Mar2024 | ₹359 Cr | 169.22 | |
| Mar2023 | ₹133 Cr | 89.34 | |
| Mar2022 | ₹70 Cr | -54.56 | |
| Mar2021 | ₹155 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,384.5 Cr | -1.6% | -10.2% | -12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -1.6% |
-10.2% |
-12% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses